Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/8/25 18:06 | 9/5/25 | BBIO | Health | Drug | Pharmaceutical Preparations | McCormick Frank | CA | D | 2 | S.d | -8,356 | 48.03 | 0 | -174 | 963 | D | ||||||||||||||||
9/8/25 18:05 | 9/4/25 | BBIO | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | 4 | S.m | -12,530 | 47.08 | 0 | -266 | 5,932 | I | |||||||||||||||
8/22/25 16:58 | 8/21/25 | BBIO | Health | Drug | Pharmaceutical Preparations | Trimarchi Thomas | CA | O | P,CFO | 2 | S | -2,962 | 49.70 | 0 | -60 | 463 | D | |||||||||||||||
8/12/25 19:06 | 8/8/25 | BBIO | Health | Drug | Pharmaceutical Preparations | Homcy Charles J | CA | D | 1 | S.m | -13,912 | 46.37 | 0 | -300 | 917 | D | ||||||||||||||||
8/11/25 18:29 | 8/7/25 | BBIO | Health | Drug | Pharmaceutical Preparations | Apuli Maricel | CA | O | Chief Ac | 1 | S | -45 | 45.44 | 0 | -1 | 142 | D | |||||||||||||||
8/7/25 16:50 | 8/5/25 | BBIO | Health | Drug | Pharmaceutical Preparations | Ellis Andrea | CA | D | 1 | S.d | -841 | 49.00 | 0 | -17 | 19 | D | ||||||||||||||||
7/1/25 19:48 | 6/27/25 | BBIO | Health | Drug | Pharmaceutical Preparations | Viking Global Investors LP | CT | T | 1 | S | -154,000 | 44.00 | 0 | -3,500 | 18,555 | I | ||||||||||||||||
6/30/25 17:51 | 6/26/25 | BBIO | Health | Drug | Pharmaceutical Preparations | Valantine Hannah | CA | D | 1 | S | -207 | 44.05 | 0 | -5 | 8 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |